Vivo Bio Tech Limited (VIVOBIOT.BO)
INR 36.76
(-0.03%)
INR 36.76
(-0.03%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Cash Flow | 155.22 Million | 73.67 Million | 150.1 Million | 141.76 Million | 86.07 Million |
| Net Income | 40.6 Million | 46.2 Million | 44.7 Million | 86.19 Million | 42.53 Million |
| Depreciation & Amortization | 91.33 Million | 92.65 Million | 74.5 Million | 55.91 Million | 51.71 Million |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - |
| Change in working capital | -24.04 Million | -54.88 Million | 53.6 Million | 29.02 Million | -10.05 Million |
| Other non-cash items | 79.35 Million | -10.3 Million | -22.7 Million | -29.37 Million | 1.88 Million |
| Investing Cash Flow | -79.5 Million | -39.97 Million | -511.1 Million | -228.21 Million | -102.34 Million |
| Investments in PPE | -79.5 Million | -39.97 Million | -511.1 Million | -228.21 Million | -102.34 Million |
| Acquisitions | - | - | - | - | - |
| Investment purchases | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - |
| Financing Cash Flow | -75.57 Million | -37.08 Million | 366.5 Million | 87.82 Million | 20.92 Million |
| Debt repayment | -13.04 Million | -69.86 Million | -354.3 Million | -49.62 Million | -7.82 Million |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | - | 32.78 Million | 12.2 Million | 38.2 Million | 13.1 Million |
| Other Financing Activities | -62.53 Million | - | 354.3 Million | 49.62 Million | 7.82 Million |
| Accounts receivables | -154.25 Million | - | 12.51 Million | 15.33 Million | - |
| Accounts payables | 130.21 Million | 27.89 Million | 29.32 Million | 13.69 Million | - |
| Inventory | - | - | - | - | - |
| Other working capital | 130.21 Million | -61.54 Million | - | - | - |
| Cash at beginning of period | 13.74 Million | 17.1 Million | 11.7 Million | 10.28 Million | 5.62 Million |
| Cash at end of period | 13.89 Million | 13.71 Million | 17.1 Million | 11.65 Million | 10.28 Million |
| Capital Expenditure | -79.5 Million | -39.97 Million | -511.1 Million | -228.21 Million | -102.34 Million |
| Effect of forex changes on cash | - | - | -100 Thousand | - | - |
| Net cash flow / Change in cash | 149 Thousand | -3.38 Million | 5.4 Million | 1.36 Million | 4.65 Million |
| Free Cash Flow | 75.72 Million | 33.69 Million | -361 Million | -86.45 Million | -16.26 Million |
| Breakdown | 2023 FY | 2022 FY | 2021 FY | 2020 FY | 2019 FY |
|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - |
| Net Income | 40.6 Million | 46.2 Million | 44.7 Million | 86.19 Million | 42.53 Million |
| Depreciation & Amortization | 91.33 Million | 92.65 Million | 74.5 Million | 55.91 Million | 51.71 Million |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - |
| Change in working capital | -24.04 Million | -54.88 Million | 53.6 Million | 29.02 Million | -10.05 Million |
| Other non-cash items | 79.35 Million | -10.3 Million | -22.7 Million | -29.37 Million | 1.88 Million |
| Investing Cash Flow | -79.5 Million | -39.97 Million | -511.1 Million | -228.21 Million | -102.34 Million |
| Investments in PPE | -79.5 Million | -39.97 Million | -511.1 Million | -228.21 Million | -102.34 Million |
| Acquisitions | - | - | - | - | - |
| Investment purchases | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - |
| Financing Cash Flow | -75.57 Million | -37.08 Million | 366.5 Million | 87.82 Million | 20.92 Million |
| Debt repayment | -13.04 Million | -69.86 Million | -354.3 Million | -49.62 Million | -7.82 Million |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | - | 32.78 Million | 12.2 Million | 38.2 Million | 13.1 Million |
| Other Financing Activities | - | - | 354.3 Million | 49.62 Million | 7.82 Million |
| Accounts receivables | -154.25 Million | - | 12.51 Million | 15.33 Million | - |
| Accounts payables | 130.21 Million | 27.89 Million | 29.32 Million | 13.69 Million | - |
| Inventory | - | - | - | - | - |
| Other working capital | - | -61.54 Million | - | - | - |
| Cash at beginning of period | 13.74 Million | 17.1 Million | 11.7 Million | 10.28 Million | 5.62 Million |
| Cash at end of period | 13.89 Million | 13.71 Million | 17.1 Million | 11.65 Million | 10.28 Million |
| Capital Expenditure | -79.5 Million | -39.97 Million | -511.1 Million | -228.21 Million | -102.34 Million |
| Effect of forex changes on cash | - | - | -100 Thousand | - | - |
| Net cash flow / Change in cash | 149 Thousand | -3.38 Million | 5.4 Million | 1.36 Million | 4.65 Million |
| Free Cash Flow | 75.72 Million | 33.69 Million | -361 Million | -86.45 Million | -16.26 Million |
9644
4114
CHKP
AGYS
PNC
CHKMF